FDA Inspection 912132 — University Of Texas MD Anderson Cancer Center

University Of Texas MD Anderson Cancer Center — FEI 3011120592

The FDA completed an inspection of University Of Texas MD Anderson Cancer Center on Jan 28, 2015 in Houston, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 28, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Houston, TX (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
745321 CFR 312.56(b)Investigator non-compliance
748221 CFR 312.50General responsibilities of sponsors